Haim Bio Co., Ltd.
🇰🇷South Korea
Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)MTD, Safety and Efficacy of NYH817G and NYH100P in Monotherapy and Combination in Patients With Advanced Solid Tumors
Phase 1
- Conditions
- Advanced Solid Tumors
- Interventions
- First Posted Date
- 2020-02-10
- Last Posted Date
- 2020-10-20
- Lead Sponsor
- Haim Bio Co., Ltd.
- Target Recruit Count
- 42
- Registration Number
- NCT04262739
- Locations
- 🇰🇷
Severance Hospital, Seoul, Korea, Republic of
News
No news found